Global Leaders in
Ingredient-led Formulation Engineering
Structured delivery. Controlled manufacturing. Commercial scale.
UK based specialists in liposomes and phospholipids, we design advanced active ingredients and finished formulations around the science of the active itself, selecting the right delivery architecture for the right ingredient.
Operating within GMP-certified, FSSC ISO 22000-accredited facilities, we design and produce lipid-based systems with defined particle characteristics, controlled processing parameters and scalable manufacturing pathways.
The right architecture for the right active
Not every active ingredient behaves the same way. Solubility, polarity, particle behaviour, stability, compatibility and processing requirements all influence how an ingredient should be formulated.
At GMPriority Pharma, we do not force actives into predefined systems. We begin with the science of the ingredient, then engineer the formulation architecture around it.
Sometimes that architecture is liposomal.
Sometimes it is not.
The science decides.
Three routes to market.
Two delivery platforms.
One scientific philosophy.
We don’t force actives into systems.
We engineer systems around actives.
One scientific philosophy
SAIFx® Technology
Liposomal delivery for actives suited to encapsulation.
SAIFx® is our proprietary lipid-based delivery platform, developed for active ingredients where liposomal architecture provides a scientifically appropriate formulation pathway.
PHEDx® Technology
Phospholipid engineered delivery for actives that require a different approach.
PHEDx® was developed for active ingredients that are not naturally suited to conventional liposomal encapsulation, enabling formulation strategies built around their physicochemical profile.
Together, SAIFx® and PHEDx® reflect our ingredient-led approach to advanced formulation: not one system for every active, but the right architecture for each one.
Why GMPriority Pharma
Built by specialists in phospholipid science, nanoencapsulation and formulation development
Our work sits at the intersection of formulation science, lipid technology, ingredient development and scalable manufacturing.
From early-stage feasibility and active optimisation through to delivery architecture, stability, production and finished format development, GMPriority Pharma supports partners in transforming complex actives into commercially viable products.
Integrated Scientific and
Manufacturing Infrastructure
GMPriority Pharma operates as an integrated lipid delivery system CDMO, combining formulation development, process engineering and in-house manufacturing within a single UK facility.
From early feasibility through to validated commercial productions, programmes are developed within GMP and FSSC ISO 220000 frameworks, supporting controlled, scalable output.
Development is conducted with defined processing parameters and manufacturing constraints in mind, enabling smooth transfer from laboratory to cleanroom without reformulation or process instability.
Our infrastructure includes:
- Class 7 cleanroom manufacturing
- Fully equipped R&D laboratories
- Process-defined scale-up and batch production
- In-house analytical capability including particle size and dispersion characterisation.
This integration reduces technical risk, shortens development timelines and supports reliable commercial supply.
Delivery is designed with manufacturing in mind.
UK-based.
Science-led.
Built for commercial reality.
GMPriority Pharma operates from a fully integrated UK facility, combining scientific development, controlled manufacturing and quality oversight within a single environment.
Our expertise in lipid-based delivery systems is applied within regulated production frameworks, supporting partners from early formulation through to consistent commercial supply.
We work with brands, formulators and ingredient partners who require technical clarity, controlled execution and confidence that what is developed can be manufactured, scaled and supplied reliably.
Flexible Engagement
Consistent Standards
We work with partners who want more than commodity ingredients and off-the-shelf manufacturing.
Whether developing a differentiated branded ingredient, a technically advanced finished product, or a new formulation platform, GMPriority Pharma provides the scientific, technical and manufacturing expertise to move from concept to commercial reality.
Each programme operates within defined quality frameworks, controlled production environments and transparent development processes, ensuring reliability across scale and format.
Whether supplying ingredients or manufacturing finished products, we prioritise clarity, accountability and execution.
Regardless of route, all programmes operate within the same structured framework, ensuring consistency, transparency and reproducible performance at scale.
Contact us
Whether you require formulation, manufacturing or ingredient supply, we can define the right approach.
Structured Ingredient Partnerships
We also support branded and exclusive ingredient collaborations, where delivery systems are developed or supplied under defined partnership frameworks.
